You've just added:

Our Impact

How we're advancing cures globally

162

Medicines in the making

64

Institutions supported

31

Companies launched

17

Medicines in the clinic

13

Licenses to pharma

What sets us apart

In addition to receiving funding, every scholar is paired with a results-oriented and mission-focused team from our Therapeutics Development Center. Teams consist of a project manager and experienced pharma and business development advisors with a track record of bringing new drugs to market.

Learn More

Making discoveries partner-ready

Our pipeline represents the best science coming out of academic laboratories. Projects are selected for their innovation and potential for clinical impact. Our team proactively moves them forward to commercial viability and clinical use.

See all discoveries

The Latest

See All News
Looking at Alzheimer’s Differently

Articles

Looking at Alzheimer’s Differently

Understanding Alzheimer’s remains the scientific challenge of our generation. Seeing a challenge and unmet need, Alzheimer’s researchers supported by Harrington Discovery Institute are attacking the disease in novel ways, with some early successes.

Continue Reading
Harrington Discovery Institute Announces 2022 Grant Funding to 11 Physician-Scientists

Press Releases

Harrington Discovery Institute Announces 2022 Grant Funding to 11 Physician-Scientists

More than 150 drug discovery projects now supported by Harrington Discovery Institute

Continue Reading
A Breakthrough Topical Treatment for Skin Cancer

Articles

A Breakthrough Topical Treatment for Skin Cancer

Dr. Tang, Stanford University, Harrington Scholar, is developing patidegib, a therapry that will hopefully be the first topical drug that is safe and efficacious for Basal Cell Carcinoma (BCC) tumors (skin cancer) prevention.

Continue Reading

Sign Up

Become a part of our community and receive periodic communications with news and updates, as well as notifications of grant funding opportunities.